Track ABUS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
ABUS - Arbutus Biopharma Corp (ABUS) has a earnings per share of $1.19, up 761.1% over the past year.
Latest EPS (Actual)
$1.19
Beat Rate
50.0%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.05 | $1.19 | Beat | +2480.00% |
| Feb 2026 | -$0.03 | -$0.01 | Beat | +54.33% |
| Nov 2025 | -$0.05 | -$0.06 | Miss | -20.00% |
| Aug 2025 | -$0.09 | $0.01 | Beat | +111.11% |
| May 2025 | -$0.15 | -$0.18 | Miss | -20.00% |
| Feb 2025 | -$0.12 | -$0.10 | Beat | +14.47% |
| Nov 2024 | -$0.13 | -$0.14 | Miss | -7.69% |
| Aug 2024 | -$0.13 | -$0.15 | Miss | -15.38% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.